BIONIK LABORATORIES CORP.: 10-Q filed 2013-11-14
What BIONIK LABORATORIES CORP. reported in its quarterly report filed 2013-11-14 (fiscal Q3 2013): 12 published measures, 41 facts as tagged in accession 0001014897-13-000412.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-11-14
- Fiscal period
- fiscal Q3 2013
- Accession
- 0001014897-13-000412 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIONIK LABORATORIES CORP. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 2,967 | USD | |
| At 2012-12-31 | 4,949 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | -7,178 | USD | |
| At 2012-12-31 | 3,299 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -1,775 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -10,477 | USD | 273 |
| 2010-01-08 to 2013-09-30 | -32,391 | USD | 1362 |
| 2012-07-01 to 2012-09-30 | 1,051 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 2,840 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | -1,982 | USD | 273 |
| 2010-01-08 to 2013-09-30 | -20,883 | USD | 1362 |
| 2012-01-01 to 2012-09-30 | 3,113 | USD | 274 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 1,500 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 3,700 | USD | 273 |
| 2010-01-08 to 2013-09-30 | 24,904 | USD | 1362 |
| 2012-07-01 to 2012-09-30 | 1,500 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 7,000 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 0 | USD | 273 |
| 2010-01-08 to 2013-09-30 | 23,850 | USD | 1362 |
| 2012-01-01 to 2012-09-30 | 0 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 2,967 | USD | |
| At 2012-12-31 | 4,949 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 0 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 0 | USD | 273 |
| 2010-01-08 to 2013-09-30 | -563 | USD | 1362 |
| 2012-07-01 to 2012-09-30 | -90 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -273 | USD | 274 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 10,145 | USD | |
| At 2012-12-31 | 1,650 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 3,275 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 14,177 | USD | 273 |
| 2010-01-08 to 2013-09-30 | 56,932 | USD | 1362 |
| 2012-07-01 to 2012-09-30 | 359 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 3,887 | USD | 274 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | -91,005 | USD | |
| At 2012-12-31 | -91,005 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 3,275 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 14,177 | USD | 273 |
| 2010-01-08 to 2013-09-30 | 56,932 | USD | 1362 |
| 2012-07-01 to 2012-09-30 | 359 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 3,887 | USD | 274 |
Inspect the source
- Entity
- BIONIK LABORATORIES CORP. / CIK 0001508381
- Captured
- SEC response SHA-256
5bb7fb15cbaa342375014f08f1afdc44fc44d4a568725cfe6cc78e258108a4c6
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001508381.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))